Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertainty

Emerging clinical research with psilocybin highlights the value of the psychedelic experience on successful treatment of a multitude of psychiatric disorders. While the psychedelic trip or clinical support procedures cannot be modeled in rodents, neural processes critical to meta-learning and flexible modification of previously learned strategies can be quantified during psilocybin exposure. Here we applied computational modeling and single unit recordings from medial prefrontal cortex to characterize the effect of psilocybin using a value-based probabilistic choice task. Psilocybin improved c